These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27254960)

  • 21. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
    Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F
    Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Schmidt M; de Koning HJ; van der Aalst C; Oudkerk M; Vliegenthart R; Groen HJ; van Ginneken B; van Rikxoort EM; Zanen P
    Eur Respir J; 2015 Mar; 45(3):644-51. PubMed ID: 25614166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome.
    Fu JJ; Gibson PG; Simpson JL; McDonald VM
    Respiration; 2014; 87(1):63-74. PubMed ID: 24029561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations.
    Ahn YH; Lee KS; Park JH; Jung JH; Lee M; Jung YJ; Chung WY; Sheen S; Park KJ; Kim DJ; Kang DR; Lee JD; Yoon S; Jin XJ; Yang HM; Lim HS; Park JS; Shin JH; Tahk SJ
    Respiration; 2015; 90(3):199-205. PubMed ID: 26278777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD.
    Gietema HA; Edwards LD; Coxson HO; Bakke PS;
    Respir Med; 2013 Aug; 107(8):1201-9. PubMed ID: 23711580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.
    Waschki B; Kirsten AM; Holz O; Mueller KC; Schaper M; Sack AL; Meyer T; Rabe KF; Magnussen H; Watz H
    Am J Respir Crit Care Med; 2015 Aug; 192(3):295-306. PubMed ID: 26020495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST study.
    Incorvaia C; Russo A; Foresi A; Berra D; Elia R; Passalacqua G; Riario-Sforza GG; Ridolo E
    Eur J Phys Rehabil Med; 2014 Aug; 50(4):419-26. PubMed ID: 24691247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ["EXACO": four year follow-up of exacerbations in a cohort of patients with COPD].
    Tillie-Leblond I; Masure F;
    Rev Mal Respir; 2006 Sep; 23(4 Pt 1):377-84. PubMed ID: 17127917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 6-min walking distance: long-term follow up in patients with COPD.
    Casanova C; Cote CG; Marin JM; de Torres JP; Aguirre-Jaime A; Mendez R; Dordelly L; Celli BR
    Eur Respir J; 2007 Mar; 29(3):535-40. PubMed ID: 17107991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test in chronic obstructive pulmonary disease with severe airflow limitation].
    Bermudo G; Pomares X; Montón C; Baré M; Monsó E
    Med Clin (Barc); 2014 Oct; 143(8):349-51. PubMed ID: 24210982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical therapy for chronic obstructive pulmonary disease.
    Martinez FJ; Chang A
    Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
    Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
    Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What predicts change in pulmonary function and quality of life in asthma or COPD?
    Hesselink AE; van der Windt DA; Penninx BW; Wijnhoven HA; Twisk JW; Bouter LM; van Eijk JT
    J Asthma; 2006 Sep; 43(7):513-9. PubMed ID: 16939991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease.
    Nishijima Y; Minami S; Yamamoto S; Ogata Y; Koba T; Futami S; Komuta K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():439-44. PubMed ID: 25767381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.